RECURRENT CHILDHOOD EPENDYMOMA
Clinical trials for RECURRENT CHILDHOOD EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHILDHOOD EPENDYMOMA trials appear
Sign up with your email to follow new studies for RECURRENT CHILDHOOD EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with aggressive brain cancers: early trial tests immune therapy
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children with aggressive brain tumors that have come back or stopped responding to standard treatments. The drug is an immunotherapy, which aims to help the body's own immune sy…
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted drug trial offers hope for kids with Tough-to-Treat cancers
Disease control OngoingThis study is testing a drug called erdafitinib in children and young adults with advanced cancers that have returned or not responded to standard treatments. It is for patients whose tumors have specific genetic changes (FGFR mutations). The goal is to see if the drug, which is …
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC